Global Gynecology Surgical Devices Market - 2023-2030
Global Gynecology Surgical Devices Market reached US$ 8.7 billion in 2022 and is expected to reach US$ 16.1 billion by 2030, growing with a CAGR of 6.5% during the forecast period 2023-2030.
The range of gynecology surgery instruments includes curettes and scoops, hysterectomy instruments, uterine dilators, probes, vulva and urethral spreaders, vaginal speculums, and myoma screws and knives. The increase in the number of launches and increase in the strategies by the companies are expected to drive the market growth.
The North America region is expected to hold a significant position in the market share. The increase in the number of launches by the key companies and their collaborations are expected to hold the region in the dominant position. The hysteroscopy segment holds a significant market share. The increased number of treatment launches associated with the devices expected to hold the segment in the leading position.
Dynamics
Increased Number of Launches of the Devices are Expected to Accelerate the Market Growth
An increased number of product launches and an increase in technological advancements will drive market growth. The launches of highly advanced products also contribute to the growth of the market. For instance, on 01 November 2022, India Medtronic, a wholly owned subsidiary of Medtronic plc, stated the launch of the TruClear system, a mechanical hysteroscopic tissue removal system used for the safe and effective treatment of intrauterine abnormalities (IUA).
Additionally, on June 06, 2023, Ceek Women's Health, a medical device company, launched the Nella Single-Use Vaginal Speculum with Integrated Sidewall Retractors and LED Light. The Nella Single-Use vaginal speculum is a unique product that combines several features into one easy-to-use device. Thus, the launches of the devices are expected to drive the market growth.
Increase in the Gynecological Surgeries are Expected to Drive the Market Growth
Increase in the number of gynecological surgeries is expected to drive the market growth. The increase in the number of hysterectomy surgeries is expected to drive the market growth. For instance, according to the Regents of the University of Michigan, Hysterectomy is the second most common surgery performed on reproductive-age women in the U.S. after cesarean section. More than 400,000 hysterectomies are performed in the U.S. each year, with nearly 68 percent done for benign conditions that involve abnormal uterine bleeding, uterine fibroids, and endometriosis.
Additionally, according to NHS England, it is estimated that 235,223 referrals to colposcopy were reported in 2021-22, an increase of 33.2% from 2020-21 (176,561). 67.7% of referrals were reported as being triggered by a screening test, and 20.8% of referrals were clinically indicated as the women holding the symptoms of cervical abnormality. Thus, the increase in the number of coloscopy procedures is also involved in driving the market growth. Safety Issues Associated with Few Gynecology Surgical Devices are Expected to Hamper the Market Growth.
Some of the complications of the surgical devices are infection, abdominal wall hematoma, and postoperative urinary retention. Short-term voiding dysfunction after placement of a synthetic mid-urethral sling is common. Additionally, the cost associated with the devices can affect the market growth. High costs of the devices create alternative choices and options for the patients. Furthermore, stringent regulatory approval procedures to ensure product safety are restraining the market's growth.
Segment AnalysisThe global gynecology surgical devices market is segmented based on product type, application, end-user, and region.
Hysteroscopy Segment Holds a Significant Position in the Market Share
The increased number of launches of hysteroscopy devices is holding the segment in the dominant market share. For instance, on September 30, 2021, Hologic, Inc., a global leader in women's health, has launched its expanded Omni suite, a comprehensive gynecological surgical offering designed to optimize diagnostic and operative hysteroscopy in Europe, Africa, and the Middle East (EMEA). The offering includes a versatile Omni 30° hysteroscope, the Omni Lok cervical seal and the Omni 5 French seal, which complement the company’s existing portfolio of GYN surgical solutions and extend physicians’ choices.
Additionally, on July 27, 2023, GenWorks, a healthcare solutions provider launched its mechanical hysteroscopic tissue removal system which uses a simple mechanical approach for removing intrauterine tissues. This is an effective solution that offers better access and improved outcomes. Thus, increase in the number of launches of the hysteroscopes are elevating the market growth.
Geographical PenetrationNorth America Holds the Largest Market Share in the Global Gynecology Surgical Devices Market
North America is expected to hold a significant market share. The increased number of company collaborations and launches of the products in the region are holding the region in the leading market share. For instance, on November 30, 2022, Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures launched the moresolution Power Morcellator, which is manufactured by TROKAMED GmbH and is available in the U.S. through a distribution agreement with Olympus America, Inc. The moresolution Morcellator is designed for advanced gynecologic procedures with large, calcified tissue specimens.
On August 12, 2021, Innovia Medical launched a single-use instrument product line called Cervical Rotating Biopsy Punch in the U.S. It supports urgently needed procedures like cancer diagnosis. Thus, the number of launches of the products in the region by the major players expands the growth of the region in the market share.
Competitive LandscapeThe global gynecology surgical devices market is fragmented, with the presence of many local and international players. Ethicon Inc., Cooper Companies Inc., Medtronic, Hologic, Inc., KARL STORZ SE & Co. KG, Boston Scientific Corporation, Olympus Corporation, Stryker, SternMed GmbH., and Richard Wolf GmbH are the leading Companies with a significant market share.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global gynecological surgical devices market growth. The COVID-19 pandemic caused disruption in consultation for gynecological disease diagnoses such as abdominal diseases, uterine infections, and others. The delayed consultations have impacted the treatment processes and, thus, impacted the market growth.
The delay in manufacturing the surgical devices by the key companies and the stringent rules and regulations by the governments have impacted the market growth. Thus, COVID-19 has impacted the market growth negatively. Thus, this factor was anticipated to restrain the demand for gynecology surgical devices market and restrain the market growth.
By Product Type
• Trocars
• Vaginal Speculums
• Uterine Curettes
• Scissors
• Needle Holders
• Dilators
• Uterine Depressors
By End-User
• Hospitals
• Clinics
• Ambulatory Surgical Centers
By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa
Why Purchase the Report?• To visualize the global gynecology surgical devices market segmentation based on product type, end-user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of gynecology surgical devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global gynecology surgical devices market report would provide approximately 61 tables, 58 figures, and 186 Pages.
Target Audience 2023• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies